Systemic corticosteroids are able to block nuclear translocation of nuclear factor- kB, the main pathway of inflammatory cytokine synthesis, through their interaction with the glucocorticoid receptor, however, the use of corticosteroid in ARDS is not recommended routinely [37, 38]. Here, NR3C1 is linked to acute respiratory distress syndrome.